Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026)
Orthofix Medical (OFIX) posted Income from Continuing Operations of 20908000.0 for Q1 2026, down 1734.04% on a QoQ basis from 1140000.0 in Q4 2025, and up 60.62% year-over-year from 13016995.22 in Q1 2025.
Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Orthofix Medical's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 20908000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 60.62% year-over-year to 20908000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41237000.0 (up 70.79% YoY) and the FY2025 annual result came in at 91110000.0, up 26.59% from the prior year.
- Income from Continuing Operations was 20908000.0 for Q1 2026 at Orthofix Medical, down from 1140000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 3606000.0 in Q2 2025 and bottomed at 60938000.0 in Q1 2023.
- A 5-year average of 19449235.29 and a median of 20908000.0 in 2026 frame the typical range for Income from Continuing Operations.
- Peak annual rise in Income from Continuing Operations reached 110.78% in 2025, while the deepest fall reached 24255.05% in 2025.
- Orthofix Medical's Income from Continuing Operations stood at 5844000.0 in 2022, then sank by 279.43% to 22174000.0 in 2023, then declined by 22.95% to 27263000.0 in 2024, then jumped by 95.82% to 1140000.0 in 2025, then tumbled by 1734.04% to 20908000.0 in 2026.
- Business Quant data shows OFIX's Income from Continuing Operations at 20908000.0 in Q1 2026, 1140000.0 in Q4 2025, and 22795000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthofix Medical | 443.33 Mn | 322.46 Mn | 139.55 Mn | -20.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.91 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -22.80 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | -53.09 Mn |
| Dec 31, 2024 | -27.26 Mn |
| Sep 30, 2024 | -27.39 Mn |
| Jun 30, 2024 | -33.44 Mn |
| Mar 31, 2024 | -218,000.00 |
| Dec 31, 2023 | -22.17 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -39.43 Mn |
| Mar 31, 2023 | -60.94 Mn |
| Dec 31, 2022 | -5.84 Mn |
| Sep 30, 2022 | -10.72 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Mar 31, 2022 | -4.46 Mn |
| Dec 31, 2021 | -812,000.00 |
| Sep 30, 2021 | -334,000.00 |
| Jun 30, 2021 | 4.64 Mn |